Coronavirus raises fears of U.S. drug supply disruptions – The Washington Post

Thanks! Share it with your friends!

Close

On an earnings call in early February, another Indian generic company, Sun Pharmaceutical Industries, described the complexity of the supply chain. Some raw materials come almost exclusively from China, Dilip Shanghvi, managing director of Sun said, including antibiotics such as azithromycin, penicillin and cephalosporin. In a sign of how the supply chain can be hard to unravel, he noted that raw materials that were purchased in India might depend on ingredients sourced in China.

Source Article from https://www.washingtonpost.com/health/2020/02/26/coronavirus-raises-fears-us-drug-supply-disruptions/

Comments

Write a comment